Gyon Technologies Capital Management, LP Gilead Sciences, Inc. Transaction History

Gyon Technologies Capital Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $1.59 Million - $1.81 Million	26,675 Added 477.02%	32,267 $1.99 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $124,386 - $140,096	-2,155 Reduced 27.82%	5,592 $346,000
Q1 2022 May 12, 2022	BUY	$57.92 - $72.58 $448,706 - $562,277	7,747 New	7,747 $461,000
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $1.03 Million - $1.13 Million	-16,252 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $3.78 Million - $4.31 Million	-63,023 Reduced 79.5%	16,252 $1.05 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $3.64 Million - $4.15 Million	64,285 Added 428.85%	79,275 $4.62 Million
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $285,287 - $358,699	4,594 Added 44.19%	14,990 $947,000
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $752,046 - $873,264	10,396 New	10,396 $800,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.